157 related articles for article (PubMed ID: 23866362)
41. Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
Danesi R; De Braud F; Fogli S; Di Paolo A; Del Tacca M
Trends Pharmacol Sci; 2001 Aug; 22(8):420-6. PubMed ID: 11479005
[TBL] [Abstract][Full Text] [Related]
42. Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics.
Cavaletti G; Alberti P; Marmiroli P
Lancet Oncol; 2011 Nov; 12(12):1151-61. PubMed ID: 21719347
[TBL] [Abstract][Full Text] [Related]
43. Implementation of pharmacogenetics in clinical practice is challenging.
van Schie RM; de Boer A; Maitland-van der Zee AH
Pharmacogenomics; 2011 Sep; 12(9):1231-3. PubMed ID: 21919599
[No Abstract] [Full Text] [Related]
44. From the lab to the clinic: integration of pharmacogenics into clinical development.
Hoban CJ
Pharmacogenomics; 2002 Jul; 3(4):429-36. PubMed ID: 12164766
[No Abstract] [Full Text] [Related]
45. New perspectives in personalised medicine for ethnicity in cancer: population pharmacogenomics and pharmacometrics.
Nair S; LLerena A
Drug Metab Pers Ther; 2018 Jun; 33(2):61-64. PubMed ID: 29688886
[No Abstract] [Full Text] [Related]
46. Pharmacogenomics in children.
Rieder M
Methods Mol Biol; 2014; 1175():687-707. PubMed ID: 25150881
[TBL] [Abstract][Full Text] [Related]
47. Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.
Gervasini G; BenÃtez J; Carrillo JA
Eur J Clin Pharmacol; 2010 Aug; 66(8):755-74. PubMed ID: 20582584
[TBL] [Abstract][Full Text] [Related]
48. Pharmacogenetics in oncology: a promising field.
Houtsma D; Guchelaar HJ; Gelderblom H
Curr Pharm Des; 2010; 16(2):155-63. PubMed ID: 20205661
[TBL] [Abstract][Full Text] [Related]
49. Aiming for the future: clinical trials study the personalized treatments of tomorrow.
Coghill AS
ONS Connect; 2013 Dec; 28(4):36-40. PubMed ID: 24400579
[No Abstract] [Full Text] [Related]
50. iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research.
Chen X; Guo Y; Chen X
Genomics Proteomics Bioinformatics; 2020 Apr; 18(2):150-160. PubMed ID: 32916316
[TBL] [Abstract][Full Text] [Related]
51. Personalized medicine: through the looking glass of functional imaging.
Hohl RJ
Clin Cancer Res; 2013 Aug; 19(15):4024-6. PubMed ID: 23785049
[TBL] [Abstract][Full Text] [Related]
52. Rethinking cancer clinical trials for the future.
Galsky MD
Future Oncol; 2014; 10(9):1545-7. PubMed ID: 25145425
[No Abstract] [Full Text] [Related]
53. Pharmacogenetic application in drug development and clinical trials.
Shi MM; Bleavins MR; de la Iglesia FA
Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):591-5. PubMed ID: 11259358
[TBL] [Abstract][Full Text] [Related]
54. Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatry.
de Leon J
Acta Neuropsychiatr; 2014 Dec; 26(6):327-33. PubMed ID: 25455256
[TBL] [Abstract][Full Text] [Related]
55. [Personalised medicine. Paradigm shift within drug research and therapy].
Stock G; Sydow S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1495-501. PubMed ID: 24170078
[TBL] [Abstract][Full Text] [Related]
56. The potential of a placebo/nocebo effect in pharmacogenetics.
Haga SB; Warner LR; O'Daniel J
Public Health Genomics; 2009; 12(3):158-62. PubMed ID: 19204418
[TBL] [Abstract][Full Text] [Related]
57. A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies.
Neely ML; Bondell HD; Tzeng JY
Biometrics; 2015 Jun; 71(2):529-37. PubMed ID: 25604216
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic procedures for paraffin-embedded tissues analysis in pharmacogenomic studies.
Palmirotta R; De Marchis ML; Ludovici G; Ferroni P; Abete P; Guadagni F; Della-Morte D
Methods Mol Biol; 2014; 1175():45-65. PubMed ID: 25150866
[TBL] [Abstract][Full Text] [Related]
59. Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continues.
Gillis NK; Innocenti F
Clin Pharmacol Ther; 2014 Dec; 96(6):655-7. PubMed ID: 25399714
[TBL] [Abstract][Full Text] [Related]
60. [Individualized cancer therapy and treatment based on syndrome differentiation].
Wang ZY
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):158-60. PubMed ID: 23714675
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
